Thromboembolic events associated with immunoglobulin treatment-Reference-Cited by-同舟云学术

Thromboembolic events associated with immunoglobulin treatment

Published:2013-02-09 Issue:1 Volume:105 Page:54-64
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Funk M. B.¹,Gross N.²,Gross S.²,Hunfeld A.³,Lohmann A.¹,Guenay S.¹,Hanschmann K. M.⁴,Keller-Stanislawski B.¹

Affiliation:

1. Department of Safety of Medicinal Products and Medical Devices; Paul-Ehrlich-Institut; Langen; Germany

2. Department of Immunology; Paul-Ehrlich-Institut; Langen; Germany

3. Department of Haematology/Transfusion Medicine; Paul-Ehrlich-Institut; Langen; Germany

4. Department of Biostatistics; Paul-Ehrlich-Institut; Langen; Germany

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vox.12025/fullpdf

Reference19 articles.

1. Core SPC for human normal immunoglobulin for intravenous administration (IVIg) (CPMP/BPWG/859/95 rev. 2);European Medicines Agency;Committee for Medicinal Products for Human Use,2004

2. Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products;Etscheid;Vox Sang,2012

3. Core SPC for human normal immunoglobulin for subcutaneous and intramuscular use (CPMP/BPWG/282/00);The European Agency for the Evaluation of Medicinal Products;Committee for Medicinal Products for Human Use,2002

4. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events;Dalakas;Neurology,1994

5. Review: intravenous immunoglobulin therapy and thromboembolic complications;Katz;Lupus,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Submicron immunoglobulin particles exhibit FcγRII-dependent toxicity linked to autophagy in TNFα-stimulated endothelial cells;Cellular and Molecular Life Sciences;2024-08-30

2. Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation;Frontiers in Cardiovascular Medicine;2023-11-22

3. Biochemical Characterization of a New 10% IVIG Preparation [IgG Next Generation (BT595)/Yimmugo®] Obtained from a Manufacturing Process Preserving IgA/IgM Potential of Human Plasma;Drugs in R&D;2023-07-19

4. Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation;Blood Advances;2023-06-05

5. Appropriately specifying the quality of plasma for fractionation;Vox Sanguinis;2021-07-30